203 related articles for article (PubMed ID: 38681210)
1. Dynasore Alleviates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Mediated Pyroptosis.
Shan M; Wan H; Ran L; Ye J; Xie W; Lu J; Hu X; Deng S; Zhang W; Chen M; Wang F; Guo Z
Drug Des Devel Ther; 2024; 18():1369-1384. PubMed ID: 38681210
[TBL] [Abstract][Full Text] [Related]
2. Alpha-linolenic acid pretreatment alleviates NETs-induced alveolar macrophage pyroptosis by inhibiting pyrin inflammasome activation in a mouse model of sepsis-induced ALI/ARDS.
Liu C; Zhou Y; Tu Q; Yao L; Li J; Yang Z
Front Immunol; 2023; 14():1146612. PubMed ID: 37051243
[TBL] [Abstract][Full Text] [Related]
3. Tangeretin attenuates acute lung injury in septic mice by inhibiting ROS-mediated NLRP3 inflammasome activation via regulating PLK1/AMPK/DRP1 signaling axis.
Liu Y; Zhang Y; You G; Zheng D; He Z; Guo W; Antonina K; Shukhrat Z; Ding B; Zan J; Zhang Z
Inflamm Res; 2024 Jan; 73(1):47-63. PubMed ID: 38147126
[TBL] [Abstract][Full Text] [Related]
4. Xuanbai Chengqi Decoction alleviates acute lung injury by inhibiting NLRP3 inflammasome.
Wang S; Lin F; Zhang C; Gao D; Qi Z; Wu S; Wang W; Li X; Pan L; Xu Y; Tan B; Yang A
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117227. PubMed ID: 37751794
[TBL] [Abstract][Full Text] [Related]
5. Emodin Attenuates LPS-Induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis Signaling Pathway In vitro and In vivo.
Liu Y; Shang L; Zhou J; Pan G; Zhou F; Yang S
Inflammation; 2022 Apr; 45(2):753-767. PubMed ID: 34787801
[TBL] [Abstract][Full Text] [Related]
6. Sestrin 2 protects against LPS-induced acute lung injury by inducing mitophagy in alveolar macrophages.
Wu D; Zhang H; Wu Q; Li F; Wang Y; Liu S; Wang J
Life Sci; 2021 Feb; 267():118941. PubMed ID: 33359748
[TBL] [Abstract][Full Text] [Related]
7. Pirfenidone ameliorates lipopolysaccharide-induced pulmonary inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Li Y; Li H; Liu S; Pan P; Su X; Tan H; Wu D; Zhang L; Song C; Dai M; Li Q; Mao Z; Long Y; Hu Y; Hu C
Mol Immunol; 2018 Jul; 99():134-144. PubMed ID: 29783158
[TBL] [Abstract][Full Text] [Related]
8. Garlic oil supplementation blocks inflammatory pyroptosis-related acute lung injury by suppressing the NF-κB/NLRP3 signaling pathway via H
Dilxat T; Shi Q; Chen X; Liu X
Aging (Albany NY); 2024 Apr; 16(7):6521-6536. PubMed ID: 38613798
[TBL] [Abstract][Full Text] [Related]
9. Intranasal Application of Budesonide Attenuates Lipopolysaccharide-Induced Acute Lung Injury by Suppressing Nucleotide-Binding Oligomerization Domain-Like Receptor Family, Pyrin Domain-Containing 3 Inflammasome Activation in Mice.
Dong L; Zhu YH; Liu DX; Li J; Zhao PC; Zhong YP; Chen YQ; Xu W; Zhu ZQ
J Immunol Res; 2019; 2019():7264383. PubMed ID: 30937316
[TBL] [Abstract][Full Text] [Related]
10. Maresin 1 protects against lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting macrophage pyroptosis and inflammatory response.
Yang W; Tao K; Zhang P; Chen X; Sun X; Li R
Biochem Pharmacol; 2022 Jan; 195():114863. PubMed ID: 34861244
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol alleviates acute lung injury in mice by promoting Pink1/Parkin-related mitophagy and inhibiting NLRP3 inflammasome activation.
Wu D; Zhang H; Li F; Liu S; Wang Y; Zhang Z; Wang J; Wu Q
Biochim Biophys Acta Gen Subj; 2024 Jul; 1868(7):130612. PubMed ID: 38626830
[TBL] [Abstract][Full Text] [Related]
12. Dihydromyricetin Alleviates Sepsis-Induced Acute Lung Injury through Inhibiting NLRP3 Inflammasome-Dependent Pyroptosis in Mice Model.
Wang YC; Liu QX; Zheng Q; Liu T; Xu XE; Liu XH; Gao W; Bai XJ; Li ZF
Inflammation; 2019 Aug; 42(4):1301-1310. PubMed ID: 30887396
[TBL] [Abstract][Full Text] [Related]
13. Andrographolide Derivative AL-1 Ameliorates LPS-induced Acute Lung Injury by Inhibiting NLRP3 Inflammasome and Lung Permeability.
Li T; Zhang C; Wei Y; Zhong H; Shan L; Yu P; Wang Y; Xu L
Curr Pharm Des; 2022; 28(30):2508-2517. PubMed ID: 35909279
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of total glucosides of White Paeony Capsules in ameliorating acute lung injury based on NLRP3 inflammasome].
Xu YJ; Wang XL; Mu WQ; Wen JC; Wang Y; Xiu Y; Dong X; Li JJ; Zhan XY; Xiao XH; Bai ZF
Zhongguo Zhong Yao Za Zhi; 2024 May; 49(10):2754-2765. PubMed ID: 38812176
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism for regulating lung immune homeostasis: Zukamu granules alleviated acute lung injury in mice by inhibiting NLRP3 inflammasome activation and regulating Th17/Treg cytokine balance.
Yu C; Li Y; Li Y; Li S; Zeng F; Yu J; Ji Z; Li K; Zhai H
J Ethnopharmacol; 2024 Apr; 324():117831. PubMed ID: 38280662
[TBL] [Abstract][Full Text] [Related]
16. PKR suppress NLRP3-pyroptosis pathway in lipopolysaccharide-induced acute lung injury model of mice.
Zeng Y; Qin Q; Li K; Li H; Song C; Li Y; Dai M; Lin F; Mao Z; Li Q; Long Y; Fan Y; Pan P
Biochem Biophys Res Commun; 2019 Oct; 519(1):8-14. PubMed ID: 31474337
[TBL] [Abstract][Full Text] [Related]
17. Mechanical Ventilation Exacerbates Poly (I:C) Induced Acute Lung Injury: Central Role for Caspase-11 and Gut-Lung Axis.
Jin S; Ding X; Yang C; Li W; Deng M; Liao H; Lv X; Pitt BR; Billiar TR; Zhang LM; Li Q
Front Immunol; 2021; 12():693874. PubMed ID: 34349759
[TBL] [Abstract][Full Text] [Related]
18. A COX-2/sEH dual inhibitor PTUPB alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting NLRP3 inflammasome activation.
Yang HH; Duan JX; Liu SK; Xiong JB; Guan XX; Zhong WJ; Sun CC; Zhang CY; Luo XQ; Zhang YF; Chen P; Hammock BD; Hwang SH; Jiang JX; Zhou Y; Guan CX
Theranostics; 2020; 10(11):4749-4761. PubMed ID: 32308747
[No Abstract] [Full Text] [Related]
19. Total tanshinones protect against acute lung injury through the PLCγ2/NLRP3 inflammasome signaling pathway.
Li X; Qiu H; Gan J; Liu Z; Yang S; Yuan R; Gao H
J Ethnopharmacol; 2023 Oct; 314():116478. PubMed ID: 37121449
[TBL] [Abstract][Full Text] [Related]
20. Loganin alleviates sepsis-induced acute lung injury by regulating macrophage polarization and inhibiting NLRP3 inflammasome activation.
Zhang J; Wang C; Wang H; Li X; Xu J; Yu K
Int Immunopharmacol; 2021 Jun; 95():107529. PubMed ID: 33744777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
